{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:55:53Z","timestamp":1761155753575},"reference-count":32,"publisher":"Elsevier BV","issue":"8","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.vaccine.2013.12.058","type":"journal-article","created":{"date-parts":[[2014,1,4]],"date-time":"2014-01-04T17:45:15Z","timestamp":1388857515000},"page":"918-923","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Immunotherapeutics to prevent the replication of Brucella in a treatment failure mouse model"],"prefix":"10.1016","volume":"32","author":[{"given":"N.","family":"Jain-Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Contreras-Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.P.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.K.","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.G.","family":"Witonsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Isloor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Vemulapalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.M.","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Sriranganathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"April\u2013June (2)","key":"10.1016\/j.vaccine.2013.12.058_bib0005","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3201\/eid0302.970219","article-title":"Brucellosis: an overview","volume":"3","author":"Corbel","year":"1997","journal-title":"Emerg Infect Dis"},{"issue":"Suppl. November (1)","key":"10.1016\/j.vaccine.2013.12.058_bib0010","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/j.ijantimicag.2010.06.015","article-title":"Update on brucellosis: therapeutic challenges","volume":"36","author":"Solera","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.vaccine.2013.12.058_bib0015","first-page":"1","volume":"vol. 740","year":"1986"},{"issue":"March (1)","key":"10.1016\/j.vaccine.2013.12.058_bib0020","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1600-065X.2010.00982.x","article-title":"An evolutionary strategy for a stealthy intracellular Brucella pathogen","volume":"240","author":"Martirosyan","year":"2011","journal-title":"Immunol Rev"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2013.12.058_bib0025","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/clinids\/20.5.1241","article-title":"Characteristics of and risk factors for relapse of brucellosis in humans","volume":"20","author":"Ariza","year":"1995","journal-title":"Clin Infect Dis"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2013.12.058_bib0030","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.1128\/IAI.00761-12","article-title":"Crucial role of gamma interferon-producing CD4+ Th1 cells but dispensable function of CD8+ T cell, B, cell, Th2, and Th17 responses in the control of Brucella melitensis infection in mice","volume":"80","author":"Vitry","year":"2012","journal-title":"Infect Immun"},{"issue":"July (2)","key":"10.1016\/j.vaccine.2013.12.058_bib0035","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1086\/341449","article-title":"Diminished production of T helper 1 cytokines correlates with T cell unresponsiveness to Brucella cytoplasmic proteins in chronic human brucellosis","volume":"186","author":"Giambartolomei","year":"2002","journal-title":"J Infect Dis"},{"issue":"November (5)","key":"10.1016\/j.vaccine.2013.12.058_bib0040","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jinf.2005.11.024","article-title":"Dominant Th1 cytokine production in early onset of human brucellosis followed by switching towards Th2 along prolongation of disease","volume":"53","author":"Rafiei","year":"2006","journal-title":"J Infect"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2013.12.058_bib0045","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1286-4579(02)00076-X","article-title":"Delayed type hypersensitivity-associated disruption of splenic periarteriolar lymphatic sheaths coincides with temporary loss of IFN-gamma production and impaired eradication of bacteria in Brucella abortus-infected mice","volume":"5","author":"Hort","year":"2003","journal-title":"Microbes Infect"},{"issue":"September (18)","key":"10.1016\/j.vaccine.2013.12.058_bib0050","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1038\/sj.gt.3302057","article-title":"Therapeutic effect of DNA vaccines combined with chemotherapy in a latent infection model after aerosol infection of mice with Mycobacterium tuberculosis","volume":"10","author":"Ha","year":"2003","journal-title":"Gene Ther"},{"issue":"July (6741)","key":"10.1016\/j.vaccine.2013.12.058_bib0055","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/22326","article-title":"Therapy of tuberculosis in mice by DNA vaccination","volume":"400","author":"Lowrie","year":"1999","journal-title":"Nature"},{"issue":"December (4)","key":"10.1016\/j.vaccine.2013.12.058_bib0060","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1620\/tjem.201.221","article-title":"The effect of levamisole combined with the classical treatment in chronic brucellosis","volume":"201","author":"Irmak","year":"2003","journal-title":"Tohoku J Exp Med"},{"issue":"November (4)","key":"10.1016\/j.vaccine.2013.12.058_bib0065","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3109\/08923979409019745","article-title":"Immunotherapy in chronic brucellosis. Effect of levamisole and interferon; mechanisms of action and clinical value","volume":"16","author":"Printzis","year":"1994","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"August (16)","key":"10.1016\/j.vaccine.2013.12.058_bib0075","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.1128\/JB.181.16.4725-4733.1999","article-title":"Structures of gram-negative cell walls and their derived membrane vesicles","volume":"181","author":"Beveridge","year":"1999","journal-title":"J Bacteriol"},{"issue":"November (22)","key":"10.1016\/j.vaccine.2013.12.058_bib0080","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1101\/gad.1299905","article-title":"Bacterial outer membrane vesicles and the host\u2013pathogen interaction","volume":"19","author":"Kuehn","year":"2005","journal-title":"Genes Dev"},{"key":"10.1016\/j.vaccine.2013.12.058_bib0085","doi-asserted-by":"crossref","first-page":"352493","DOI":"10.1155\/2012\/352493","article-title":"Characterization of outer membrane vesicles from Brucella melitensis and protection induced in mice","volume":"2012","author":"Avila-Calderon","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.vaccine.2013.12.058_bib0090","article-title":"Pluronic P85 enhances the efficacy of outer membrane vesicles as a subunit vaccine against Brucella melitensis challenge in mice","volume":"October","author":"Jain-Gupta","year":"2012","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"September (2)","key":"10.1016\/j.vaccine.2013.12.058_bib0095","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jconrel.2008.04.013","article-title":"Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers","volume":"130","author":"Batrakova","year":"2008","journal-title":"J Control Release"},{"issue":"October (69)","key":"10.1016\/j.vaccine.2013.12.058_bib0100","first-page":"947","article-title":"A new species of Brucella isolated from the desert wood rat, Neotoma lepida Thomas","volume":"18","author":"Stoenner","year":"1957","journal-title":"Am J Vet Res"},{"issue":"January (4)","key":"10.1016\/j.vaccine.2013.12.058_bib0105","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.vaccine.2010.11.018","article-title":"Immunization of mice with gamma-irradiated Brucella neotomae and its recombinant strains induces protection against virulent B. abortus, B. melitensis, and B. suis challenge","volume":"29","author":"Moustafa","year":"2011","journal-title":"Vaccine"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2013.12.058_bib0110","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1128\/IAI.68.6.3286-3289.2000","article-title":"Overexpression of protective antigen as a novel approach to enhance vaccine efficacy of Brucella abortus strain RB51","volume":"68","author":"Vemulapalli","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.12.058_bib0115","first-page":"62","article-title":"Studies of Brucella lipopolysaccharide","volume":"31","author":"Jones","year":"1976","journal-title":"Dev Biol Stand"},{"issue":"October (2)","key":"10.1016\/j.vaccine.2013.12.058_bib0120","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1574-695X.1995.tb00180.x","article-title":"Antibiotic treatment induces an increase of the specific antibody levels in Brucella melitensis infected mice","volume":"12","author":"Domingo","year":"1995","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2013.12.058_bib0125","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1128\/JCM.11.6.691-693.1980","article-title":"2-Mercaptoethanol Brucella agglutination test: usefulness for predicting recovery from brucellosis","volume":"11","author":"Buchanan","year":"1980","journal-title":"J Clin Microbiol"},{"issue":"September\u2013October (5)","key":"10.1016\/j.vaccine.2013.12.058_bib0130","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/clinids\/5.5.821","article-title":"Human brucellosis","volume":"5","author":"Young","year":"1983","journal-title":"Rev Infect Dis"},{"issue":"October (16)","key":"10.1016\/j.vaccine.2013.12.058_bib0135","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJM195210162471605","article-title":"Some biologic and clinical problems related to intracellular parasitism in brucellosis","volume":"247","author":"Spink","year":"1952","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2013.12.058_bib0140","doi-asserted-by":"crossref","first-page":"327346","DOI":"10.1155\/2008\/327346","article-title":"Chronic brucellosis patients retain low frequency of CD4+ T-lymphocytes expressing CD25 and CD28 after Escherichia coli LPS stimulation of PHA-cultured PBMCs","volume":"2008","author":"Skendros","year":"2008","journal-title":"Clin Dev Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2013.12.058_bib0145","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1348-0421.2006.tb03810.x","article-title":"Characterization of biological activities of Brucella melitensis lipopolysaccharide","volume":"50","author":"Tumurkhuu","year":"2006","journal-title":"Microbiol Immunol"},{"issue":"February (8)","key":"10.1016\/j.vaccine.2013.12.058_bib0150","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.vaccine.2010.12.068","article-title":"Outer membrane vesicles obtained from Bordetella pertussis Tohama expressing the lipid A deacylase PagL as a novel acellular vaccine candidate","volume":"29","author":"Asensio","year":"2011","journal-title":"Vaccine"},{"issue":"May\u2013June (3)","key":"10.1016\/j.vaccine.2013.12.058_bib0155","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0769-2625(87)80052-1","article-title":"Immunity conferred upon mice by anti-LPS monoclonal antibodies in murine brucellosis","volume":"138","author":"Limet","year":"1987","journal-title":"Ann Inst Pasteur Immunol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2013.12.058_bib0160","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1128\/IAI.60.1.312-315.1992","article-title":"Protection against Brucella melitensis or Brucella abortus in mice with immunoglobulin G (IgG), IgA, and IgM monoclonal antibodies specific for a common epitope shared by the Brucella A and M smooth lipopolysaccharides","volume":"60","author":"Cloeckaert","year":"1992","journal-title":"Infect Immun"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2013.12.058_bib0165","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1128\/IAI.51.3.961-963.1986","article-title":"Protection against Brucella abortus in mice with O-polysaccharide-specific monoclonal antibodies","volume":"51","author":"Montaraz","year":"1986","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1301801X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1301801X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T11:14:14Z","timestamp":1597317254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1301801X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0264410X1301801X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.12.058","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunotherapeutics to prevent the replication of Brucella in a treatment failure mouse model","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.12.058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}